Catherine A. O’Brian

3.9k total citations
90 papers, 3.1k citations indexed

About

Catherine A. O’Brian is a scholar working on Molecular Biology, Oncology and General Health Professions. According to data from OpenAlex, Catherine A. O’Brian has authored 90 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 24 papers in Oncology and 10 papers in General Health Professions. Recurrent topics in Catherine A. O’Brian's work include Protein Kinase Regulation and GTPase Signaling (28 papers), Drug Transport and Resistance Mechanisms (8 papers) and Retinoids in leukemia and cellular processes (7 papers). Catherine A. O’Brian is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (28 papers), Drug Transport and Resistance Mechanisms (8 papers) and Retinoids in leukemia and cellular processes (7 papers). Catherine A. O’Brian collaborates with scholars based in United States, Australia and Netherlands. Catherine A. O’Brian's co-authors include Nancy E. Ward, I. Bernard Weinstein, Jubilee R. Stewart, Dominic Fan, Constantin G. Ioannides, Isaiah J. Fidler, Gerard M. Housey, W.L. Wendy Hsiao, James P. Murphy and Mark D. Johnson and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Catherine A. O’Brian

87 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine A. O’Brian United States 31 1.9k 767 397 227 214 90 3.1k
J. Fred Nagelkerke Netherlands 32 1.4k 0.7× 647 0.8× 538 1.4× 370 1.6× 311 1.5× 87 3.6k
Keiichi Kawai Japan 36 1.7k 0.9× 841 1.1× 280 0.7× 224 1.0× 341 1.6× 341 5.1k
Angela Alexander United States 22 1.4k 0.7× 367 0.5× 295 0.7× 205 0.9× 293 1.4× 55 2.6k
Dan Chen China 27 2.1k 1.1× 513 0.7× 330 0.8× 210 0.9× 313 1.5× 112 3.5k
Judith A. Smith United States 33 847 0.4× 565 0.7× 466 1.2× 100 0.4× 112 0.5× 121 3.1k
Hirofumi Nakano Japan 26 1.6k 0.9× 637 0.8× 150 0.4× 218 1.0× 242 1.1× 140 3.1k
Robert Fürst Germany 32 1.4k 0.7× 352 0.5× 345 0.9× 175 0.8× 302 1.4× 119 3.7k
Mi‐Jeong Kim South Korea 28 1.7k 0.9× 308 0.4× 674 1.7× 192 0.8× 179 0.8× 88 4.6k
Jin Zhang China 33 1.9k 1.0× 780 1.0× 428 1.1× 209 0.9× 627 2.9× 131 3.6k
Bruce F. Scharschmidt United States 40 1.5k 0.8× 1.2k 1.6× 202 0.5× 388 1.7× 60 0.3× 116 4.6k

Countries citing papers authored by Catherine A. O’Brian

Since Specialization
Citations

This map shows the geographic impact of Catherine A. O’Brian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. O’Brian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. O’Brian more than expected).

Fields of papers citing papers by Catherine A. O’Brian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. O’Brian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. O’Brian. The network helps show where Catherine A. O’Brian may publish in the future.

Co-authorship network of co-authors of Catherine A. O’Brian

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. O’Brian. A scholar is included among the top collaborators of Catherine A. O’Brian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. O’Brian. Catherine A. O’Brian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Brian, Catherine A., Sharon Post, Gayle E. Woloschak, et al.. (2023). Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model. Cancer Causes & Control. 34(7). 621–624. 1 indexed citations
2.
Post, Sharon, et al.. (2022). How Should Representation of Subjects With LEP Become More Equitable in Clinical Trials?. The AMA Journal of Ethic. 24(4). E319–325. 14 indexed citations
3.
Guo, Xiaoyue, et al.. (2021). Associations between Fatalistic Cancer Beliefs and Cancer-Screening Behaviors in Chinese American Immigrant Women. Journal of Immigrant and Minority Health. 23(4). 699–706. 7 indexed citations
4.
O’Brian, Catherine A., et al.. (2021). United States' Obstetrician/Gynecologists' Readiness to Care for Women Affected by Female Genital Cutting. Journal of Women s Health. 31(3). 431–438. 6 indexed citations
5.
Tom, Laura S., et al.. (2020). Refining Trauma‐Informed Perinatal Care for Urban Prenatal Care Patients with Multiple Lifetime Traumatic Exposures: A Qualitative Study. Journal of Midwifery & Women s Health. 65(2). 224–230. 19 indexed citations
6.
7.
Stewart, Jubilee R. & Catherine A. O’Brian. (2004). Resveratrol Antagonizes EGFR-Dependent Erk1/2 Activation in Human Androgen-Independent Prostate Cancer Cells with Associated Isozyme-Selective PKCα Inhibition. Investigational New Drugs. 22(2). 107–117. 68 indexed citations
8.
Stewart, Jubilee R., et al.. (2003). Resveratrol: A Candidate Nutritional Substance for Prostate Cancer Prevention. Journal of Nutrition. 133(7). 2440S–2443S. 79 indexed citations
9.
Ward, Nancy E., F. Chu, & Catherine A. O’Brian. (2002). Regulation of Protein Kinase C Isozyme Activity by S-Glutathiolation. Methods in enzymology on CD-ROM/Methods in enzymology. 353. 89–100. 15 indexed citations
10.
Carter, Darrick, Clay L. Efferson, Nancy E. Ward, et al.. (2002). Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Complex. The Journal of Immunology. 169(7). 3545–3554. 23 indexed citations
11.
Ward, Nancy E., Richard J. Epstein, Andrzej P. Kudelka, et al.. (2002). Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro. Oncology Reports. 9(5). 929–35. 3 indexed citations
12.
Ward, Nancy E., Catherine A. O’Brian, James L. Murray, et al.. (2001). Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity. Molecular and Cellular Biochemistry. 217(1-2). 21–33. 27 indexed citations
13.
O’Brian, Catherine A., Nancy E. Ward, Jubilee R. Stewart, & F. Chu. (2001). Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story. Cancer and Metastasis Reviews. 20(1-2). 95–100. 28 indexed citations
14.
Fisk, Bryan, Cherylyn A. Savary, Catherine A. O’Brian, et al.. (1995). Changes in an HER-2 Peptide Upregulating HLA-A2 Expression Affect Both Conformational Epitopes and CTL Recognition. Journal of Immunotherapy. 18(4). 197–209. 25 indexed citations
15.
O’Brian, Catherine A., et al.. (1992). T‐cell recognition of oncogene products: A new strategy for immunotherapy. Molecular Carcinogenesis. 6(2). 77–82. 25 indexed citations
16.
Wilmanns, Christoph, Dominic Fan, Catherine A. O’Brian, Corazon D. Bucana, & Isaiah J. Fidler. (1992). Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5‐fluorouracil. International Journal of Cancer. 52(1). 98–104. 143 indexed citations
17.
Fan, Dominic, Corazon D. Bucana, Catherine A. O’Brian, et al.. (1990). Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes.. PubMed. 50(12). 3619–26. 55 indexed citations
18.
O’Brian, Catherine A. & Nancy E. Ward. (1990). Characterization of a calcium- and phospholipid-dependent ATPase reaction catalyzed by rat brain protein kinase C. Biochemistry. 29(18). 4278–4282. 13 indexed citations
19.
O’Brian, Catherine A., Constantin G. Ioannides, Nancy E. Ward, & Rob M. J. Liskamp. (1990). Inhibition of protein kinase C and calmodulin by the geometric isomers cis‐ and trans‐tamoxifen. Biopolymers. 29(1). 97–104. 29 indexed citations
20.
O’Brian, Catherine A., Dominic Fan, Nancy E. Ward, Christopher A. Seid, & Isaiah J. Fidler. (1989). Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Letters. 246(1-2). 78–82. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Fred Nagelkerke Breakdown of academic impact, for papers by Keiichi Kawai Breakdown of academic impact, for papers by Angela Alexander Breakdown of academic impact, for papers by Dan Chen Breakdown of academic impact, for papers by Judith A. Smith Breakdown of academic impact, for papers by Hirofumi Nakano Breakdown of academic impact, for papers by Robert Fürst Breakdown of academic impact, for papers by Mi‐Jeong Kim Breakdown of academic impact, for papers by Jin Zhang Breakdown of academic impact, for papers by Bruce F. Scharschmidt
Rankless by CCL
2026